BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 18, 2007
View Archived Issues
Lpath Moving Sphingomab Into Clinic With $16.8M Financing
Lpath Inc. closed the second tranche of an April private placement, for a total financing of $16.8 million to push its lead compound, the anti-angiogenic compound Sphingomab, into the clinic.(BioWorld Today)
Read More
TransOral Reports Positive Data From Phase III Trial In Insomnia
Read More
Analyst Opinion Divided On La Jolla's Riquent For Lupus
Read More
NewCo News: Tempo Hurries To Target Nanoparticle Combo Drugs
Read More
Other News To Note
Read More
Appointments And Advancements
Read More